Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "SPARC announces Complete Response Letter Resubmission for PDP-716 NDA by Ocuvex".
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "SPARC announces Complete Response Letter Resubmission for PDP-716 NDA by Ocuvex".